NasdaqCM - Delayed Quote USD

Avenue Therapeutics, Inc. (ATXI)

6.20 -2.58 (-29.35%)
At close: April 26 at 4:00 PM EDT
6.26 +0.06 (+0.97%)
After hours: April 26 at 7:57 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
14,540.00
14,540.00
8,043.00
3,738.00
5,213.00
Operating Income
-14,540.00
-14,540.00
-8,043.00
-3,738.00
-5,213.00
Net Non Operating Interest Income Expense
-206.00
-206.00
-1,140.00
7.00
62.00
Other Income Expense
4,258.00
4,258.00
5,580.00
--
--
Pretax Income
-10,488.00
-10,488.00
-3,603.00
-3,731.00
-5,151.00
Net Income Common Stockholders
-10,377.00
-10,377.00
-3,552.00
-3,731.00
-5,151.00
Diluted NI Available to Com Stockholders
-10,377.00
-10,377.00
-3,552.00
-3,731.00
-5,151.00
Basic EPS
-0.98
-0.98
-1.63
-3.29
-4.65
Diluted EPS
-0.98
-0.98
-1.63
-3.29
-4.65
Basic Average Shares
10,591.64
10,591.64
2,185.16
1,133.17
1,100.43
Diluted Average Shares
10,591.64
10,591.64
2,185.16
1,133.17
1,100.43
Total Operating Income as Reported
-14,540.00
-14,540.00
-8,043.00
-3,738.00
-5,213.00
Total Expenses
14,540.00
14,540.00
8,043.00
3,738.00
5,213.00
Net Income from Continuing & Discontinued Operation
-10,377.00
-10,377.00
-3,552.00
-3,731.00
-5,151.00
Normalized Income
-14,635.00
-14,635.00
-9,132.00
-3,731.00
-5,151.00
Interest Income
126.00
126.00
20.00
7.00
62.00
Interest Expense
332.00
332.00
1,160.00
--
--
Net Interest Income
-206.00
-206.00
-1,140.00
7.00
62.00
EBIT
-10,156.00
-10,156.00
-2,443.00
-3,731.00
-5,213.00
EBITDA
-10,156.00
-10,156.00
-2,443.00
-3,731.00
-5,213.00
Net Income from Continuing Operation Net Minority Interest
-10,377.00
-10,377.00
-3,552.00
-3,731.00
-5,151.00
Total Unusual Items Excluding Goodwill
4,258.00
4,258.00
5,580.00
--
--
Total Unusual Items
4,258.00
4,258.00
5,580.00
--
--
Normalized EBITDA
-14,414.00
-14,414.00
-8,023.00
-3,731.00
-5,213.00
12/31/2020 - 6/27/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

FBIO Fortress Biotech, Inc.
1.7200
0.00%
 
ZVSA ZyVersa Therapeutics, Inc.
4.9900
-16.83%
 
KTRA Kintara Therapeutics, Inc.
0.1488
-5.82%
 
PALI Palisade Bio, Inc.
6.05
-2.89%
 
ABVC ABVC BioPharma, Inc.
1.4200
-10.69%
 
WINT Windtree Therapeutics, Inc.
5.23
+2.55%
 
RNAZ TransCode Therapeutics, Inc.
0.5499
+5.30%
 
PCSA Processa Pharmaceuticals, Inc.
2.1500
-11.52%
 
ALLR Allarity Therapeutics, Inc.
1.4600
+2.10%
 
NBY NovaBay Pharmaceuticals, Inc.
0.0788
+2.34%